L. Savickas: decisions on the purchase of rapid tests were made by A.Veryga



[ad_1]

“The specific decision to initiate the acquisition of rapid tests and to force the National Public Health Laboratory (NSPL) to implement this acquisition was made by the head of the operation,” said L. Savickas in an interview recorded last week on delfi. lt.

“Aurelius Verygos. In the event of an emergency, the operation commander shall have that right and may make such a decision in accordance with the law. His decision forced the national laboratory to acquire rapid tests, “he added.

The LRT Research Department has previously announced that L. Savickas gave a direct order to begin the acquisition in March.

Mr Savickas stated that the role of the Government Chancellery and his then adviser to the Prime Minister in obtaining rapid evidence was “essentially coordinated”.

“The government office did not regulate or specify at what price or what specific product or supplier should be purchased. Our objective was to capture the need, recognize that it is urgent and that operational solutions are needed,” said the rector of the Government.

A.Veryga agrees that the formal decision was his

Health Minister Aurelius Veryga agrees that he formally signed the decision to buy rapid coronavirus tests.

“I can’t really go into additional details and comments, because I have signed that I cannot publish or evaluate the material from the pre-trial investigation. And formally, of course, decisions that finalize certain acquisitions are of course signed by the boss. operations, “the minister said at a news conference Monday.

He said he could not comment further on the case, recalling his commitment not to reveal material from the pre-trial investigation.

BNS recalls that FNTT investigates 6 million. purchase of rapid coronavirus tests worth EUR.

A total of six people were charged in the investigation, including Profarma, the then Deputy Minister of Health, Lina Jaruševičienė, a member of the Vilnius City Council, representative of the Freedom Party, and Redas Laukys, director of Bona Diagnosis.

According to the study, it amounts to 6 million. The company allegedly falsified the documents and provided the buyer with false information about the manufacturer of the rapid tests for COVID-19.

The acquisitions were made by the National Public Health Laboratory. Police have questioned the interim management of the laboratory. The then head of the laboratory, Vytautas Zimnickas, died in mid-July.

The Special Investigation Service is also conducting another investigation on more than 5 million. purchases of COVID-19 reagents worth € 1 million; the laboratory also bought the reagents.



[ad_2]